Strober, B. , Imafuku, S. , Paul, C., Gooderham, M., Spelman, L., Seo, S.J., Passeron, T., Hoyt, K., Colombo, M.J., Banerjee, S., Augustin, M., Stein Gold, L., Alexis, A.F., Thaci, D., Lebwohl, M., Issa, N.T. and Cameron, M.C. 2024. Deucravacitinib in Plaque Psoriasis: Maintenance of Response Over 4 Years in the Phase 3 POETYK PSO-1, PSO-2, and LTE Trials. SKIN The Journal of Cutaneous Medicine. 8, 4 (Jul. 2024), s407. DOI:https://doi.org/10.25251/skin.8.supp.407.